您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Vanillylmandelic acid-d3
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Vanillylmandelic acid-d3
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Vanillylmandelic acid-d3图片
规格:98%
分子量:201.19
包装与价格:
包装价格(元)
5mg电议
10mg电议

产品介绍
Vanillylmandelic acid-d3 是 Vanillylmandelic acid 的氘代物。Vanillylmandelic acid 是肾上腺素和去甲肾上腺素代谢的最终产物。Vanillylmandelic acid 也可作为神经递质代谢紊乱的标志物。Vanillylmandelic acid 具有抗氧化 (antioxidant) 活性,清除 DPPH 自由基的 IC50 值为 33 μM。
货号:ajcx37000
CAS:74495-70-8
分子式:C9H7D3O5
分子量:201.19
溶解度:N/A
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Vanillylmandelic acid-d3 is the deuterium labeled Vanillylmandelic acid. Vanillylmandelic acid is the endproduct of epinephrine and norepinephrine metabolism. Vanillylmandelic acid can be used as an indication of the disorder in neurotransmitter metabolism as well. Vanillylmandelic acid has antioxidant activity towards DPPH radical with an IC50 value of 33 μM[1].

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Michalis K Kolentinis, et al.Cardiovascular effects of vanillylmandelic acid in rats. Eur J Pharmacol. 2013 Mar 5;703(1-3):46-52.
[3]. Dušan Dimi?, et al. Experimental and theoretical elucidation of structural and antioxidant properties of vanillylmandelic acid and its carboxylate anion. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Jun 5;198:61-70.